Table 2.
Serial Number | Age (Years) |
BMI (kg/m2) |
Diagnosis | Grade | Stage |
---|---|---|---|---|---|
Library Generation Cohort | |||||
1 | 57 | 38 | Atypical Hyperplasia | - | - |
2 | 78 | 45 | Atypical Hyperplasia | - | - |
3 | 61 | 37 | Atypical Hyperplasia | - | - |
4 | 65 | 27 | Endometrioid Endometrial cancer | 1 | 1A |
5 | 60 | 43 | Endometrioid Endometrial cancer | 1 | 1A |
6 | 73 | 29 | Endometrioid Endometrial cancer | 2 | 1A |
7 | 52 | 30 | Endometrioid Endometrial cancer | 2 | 1A |
8 | 62 | 27 | Clear Cell Endometrial cancer | 3 | 1A |
9 | 52 | 30 | Serous Endometrial cancer | 3 | 1A |
10 | 74 | 27 | Carcinosarcoma | 3 | 1B |
11 | 72 | 27 | Mixed (Clear Cell/Endometrioid) cancer | 3 | 2 |
12 | 84 | 28 | Endometrioid Endometrial cancer | 3 | 4B |
13 | 54 | 29 | Control (No endometrial pathology) | - | - |
14 | 81 | 24 | Control (No endometrial pathology) | - | - |
15 | 56 | 24 | Control (Atrophic vaginitis) | - | - |
16 | 56 | 40 | Control (No endometrial pathology) | - | - |
17 | 52 | 44 | Control (No endometrial pathology) | - | - |
18 | 50 | 24 | Control (No endometrial pathology) | - | - |
19 | 56 | 24 | Control (No endometrial pathology) | - | - |